Efficacy and safety of nintedanib in elderly patients with progressive fibrosing interstitial lung diseases (ILDs)*

被引：0

作者：

Bonella, Autoren F. ^{[1
]}

Moua, T. ^{[2
]}

Okamoto, M. ^{[3
]}

Tomassetti, S. ^{[4
]}

Valenzuela, C. ^{[5
]}

Wuyts, W. ^{[6
]}

Miede, C. ^{[7
]}

Lievens, D. ^{[8
]}

Bendstrup, E. ^{[9
]}

机构：

[1] Univ Duisburg Essen, Zentrum Interstitielle & Seltene Lungenkrankheite, Klin Pneumol,Univ Med Essen, Ruhrlandklin,Univ Klinikum,Westdeutsch Lungenzent, Duisburg, Germany

[2] Mayo Clin Rochester, Div Pulm & Crit Care Med, Rochester, MN USA

[3] Kurume Univ, Sch Med, Div Respirol Neurol & Rheumatol, Dept Internal Med, Kurume, Fukuoka, Japan

[4] Careggi Univ Hosp, Dept Expt & Clin Med, Florence, Italy

[5] Univ Autonoma Madrid, Hosp Univ Princesa, Madrid, Spain

[6] Univ Hosp Leuven, Dept Pulm Med, Unit Interstitial Lung Dis, Leuven, Belgium

[7] Mainanalyt GmbH, Sulzbach, Germany

[8] Boehringer Ingelheim Int GmbH, Ingelheim, Germany

[9] Aarhus Univ Hosp, Dept Resp Dis & Allergy, Ctr Rare Lung Dis, Aarhus, Denmark

来源：

PNEUMOLOGIE | 2023年 / 77卷

关键词：

D O I：

10.1055/s-0043-1761002

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

Po 256

引用

页码：S57 / S57

页数：1

共 50 条

[1] Efficacy and Safety of Nintedanib in Elderly Patients with Progressive Fibrosing Interstitial Lung Diseases (ILDs)
Moua, T.
Bonella, F.
Okamoto, M.
Tomassetti, S.
Valenzuela, C.
Wuyts, W.
Miede, C.
Lievens, D.
Bendstrup, E.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
[2] Characteristics of Patients with Progressive Fibrosing Interstitial Lung Diseases (ILDs) in the INBUILD Trial of Nintedanib
Flaherty, K. R.
Wells, A. U.
Clerisme-Beaty, E.
Cottin, V.
Devaraj, A.
Inoue, Y.
Richeldi, L.
Walsh, S.
Goeldner, R.
Schlenker-Herceg, R.
Brown, K. K.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
[3] Effects of Nintedanib on Circulating Biomarkers in Subjects with Progressive Fibrosing Interstitial Lung Diseases (ILDs)
Maher, T. M.
Jenkins, R. G.
Bonella, F.
Assassi, S.
Diefenbach, C.
Ittrich, C.
Rohr, K. B.
Kolb, M.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
[4] Effects of Nintedanib in Patients with Progressive Fibrosing Interstitial Lung Diseases (ILDs) by Composite Physiologic Index (CPI)
Nambiar, A. M.
Molina-Molina, M.
Padilla, M.
Song, J.
Mueller, H.
Stowasser, S.
Rohr, K. B.
Wells, A. U.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
[5] Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
Fabre, Aurelie
Nicholson, Andrew G.
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (08): : 780 - 780
[6] Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
Flaherty, K. R.
Wells, A. U.
Cottin, V
Devaraj, A.
Walsh, S. L. F.
Inoue, Y.
Richeldi, L.
Kolb, M.
Tetzlaff, K.
Stowasser, S.
Coeck, C.
Clerisme-Beaty, E.
Rosenstock, B.
Quaresma, M.
Haeufel, T.
Goeldner, R-G
Schlenker-Herceg, R.
Brown, K. K.
NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (18): : 1718 - 1727
[7] Nintedanib in progressive fibrosing interstitial lung diseases
Hadjiski, D.
ZEITSCHRIFT FUR RHEUMATOLOGIE, 2020, 79 (04): : 393 - 394
[8] Effects of Nintedanib in Patients with Progressive Fibrosing Interstitial Lung Diseases (ILDs) Taking Anti-Acid Therapy
Kreuter, M.
Glazer, C.
Kitamura, H.
Koschel, D.
Moua, T.
Mueller, H.
Stowasser, S.
Rohr, K. B.
Brown, K. K.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
[9] Nintedanib in Progressive Fibrosing Interstitial Lung Diseases Reply
Flaherty, Kevin R.
Wells, Athol U.
Brown, Kevin K.
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (08): : 781 - 781
[10] Nintedanib for treating progressive fibrosing interstitial lung diseases
Adler, Amanda, I
Guo, Yelan
Thiam, Aminata
Elliott, Nicole
Patel, Sanjeev
LANCET RESPIRATORY MEDICINE, 2021, 9 (12): : E116 - E117

← 1 2 3 4 5 →